Genesis Healthcare, Inc. (NYSE:GEN) shares were up 7.2% during mid-day trading on Thursday . The stock traded as high as $1.10 and last traded at $1.04, with a volume of 723,201 shares traded. The stock had previously closed at $0.97.

Several research analysts have issued reports on GEN shares. ValuEngine upgraded shares of Genesis Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, June 8th. Cantor Fitzgerald started coverage on shares of Genesis Healthcare in a report on Wednesday, July 5th. They set an “overweight” rating for the company.

The company’s market capitalization is $109.88 million. The firm’s 50 day moving average is $1.28 and its 200-day moving average is $2.09.

Several institutional investors have recently made changes to their positions in GEN. Citadel Advisors LLC increased its position in shares of Genesis Healthcare by 554.3% in the first quarter. Citadel Advisors LLC now owns 200,713 shares of the company’s stock worth $530,000 after buying an additional 170,036 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Genesis Healthcare by 789.4% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 91,802 shares of the company’s stock worth $242,000 after buying an additional 81,480 shares in the last quarter. California Public Employees Retirement System increased its position in shares of Genesis Healthcare by 12.5% in the first quarter. California Public Employees Retirement System now owns 262,500 shares of the company’s stock worth $693,000 after buying an additional 29,100 shares in the last quarter. TIAA CREF Investment Management LLC increased its position in shares of Genesis Healthcare by 50.1% in the first quarter. TIAA CREF Investment Management LLC now owns 223,085 shares of the company’s stock worth $589,000 after buying an additional 74,502 shares in the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of Genesis Healthcare by 2.6% in the first quarter. Alliancebernstein L.P. now owns 83,126 shares of the company’s stock worth $219,000 after buying an additional 2,100 shares in the last quarter. Institutional investors own 14.90% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/09/02/genesis-healthcare-inc-gen-trading-up-7-2.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.